MedPath

Oxygen

Generic Name
Oxygen
Brand Names
Alnox, Ez-OX, Heliox, Oxygen, Southern Medical
Drug Type
Small Molecule
Chemical Formula
O2
CAS Number
7782-44-7
Unique Ingredient Identifier
S88TT14065

Overview

Oxygen is an element displayed by the symbol O, and atomic number 8. It is an essential element for human survival. Decreased oxygen levels may be treated with medical oxygen therapy. Treatment with oxygen serves to increase blood oxygen levels and also exerts a secondary effect of decreasing blood flow resistance in the diseased lung, leading to decreased cardiovascular workload in an attempt to oxygenate the lungs. Oxygen therapy is used to treat emphysema, pneumonia, some heart disorders (congestive heart failure), some disorders that cause increased pulmonary artery pressure, and any disease that impairs the body's ability to take up and use gaseous oxygen. Higher level of oxygen than ambient air (hyperoxia) can be introduced under normobaric or hyperbaric conditions.

Indication

Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia to reduce the extent of hypoxia-induced tissue damage and malfunction.

Associated Conditions

  • Anemia
  • Cancer
  • Hypoxemia
  • Hypoxia
  • Migraine
  • Polycythemia
  • Pulmonary Hypertension (PH)
  • Respiratory Disorders
  • Sleep Apnea

Research Report

Published: Jul 21, 2025

Oxygen (DB09140): A Comprehensive Monograph on its Chemistry, Pharmacology, and Clinical Application

Section I: Introduction and Historical Context: From "Dephlogisticated Air" to Essential Medicine

Oxygen, the most abundant element in the Earth's crust, occupies a unique and paradoxical position within the modern pharmacopeia. It is simultaneously a fundamental component of the atmosphere essential for all aerobic life and a potent, regulated prescription drug with a defined therapeutic window and significant potential for toxicity. This dual identity—as both a life-sustaining substrate and a powerful therapeutic agent—frames the central challenge of its clinical application: the judicious use of a substance that can be life-saving when correcting hypoxia but life-threatening when administered in excess. The journey of oxygen from an unknown component of air to a cornerstone of medical therapy is a story of scientific revolution, contested discovery, and evolving understanding that mirrors the maturation of chemistry and medicine itself. This report provides a comprehensive monograph on oxygen (DrugBank ID: DB09140), detailing its history, physicochemical properties, complex pharmacology, diverse clinical applications, methods of administration, safety profile, and the unique regulatory framework that governs its use.

The scientific understanding of oxygen emerged from an intellectual landscape dominated by the phlogiston theory. In the 18th century, this theory posited that all combustible materials contained a fire-like element called "phlogiston," which was released during burning. What we now call oxidation was then understood as the release of phlogiston, and the remaining ash or calx was considered "dephlogisticated". It was within this paradigm that the first investigations into the nature of air and combustion took place, setting the stage for one of chemistry's most pivotal discoveries.[1]

Continue reading the full research report

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
American Medical Gas LLC
68419-0001
RESPIRATORY (INHALATION)
99 L in 100 L
1/12/2010
Nor-Lea Hospital District dba Nor-Lea Home Medical
75928-001
RESPIRATORY (INHALATION)
99 L in 100 L
2/11/2011
Virginia Medical and Respiratory Equipment Inc
60563-001
RESPIRATORY (INHALATION)
99 L in 100 L
12/11/2023
RTA Homecare, Inc.
54982-0001
RESPIRATORY (INHALATION)
99 L in 100 L
10/29/2009
Atlanta Medical Gas LLC
42165-0001
RESPIRATORY (INHALATION)
99 L in 100 L
1/1/2010
Wilkinson Pharmacy, Inc.
24846-0001
RESPIRATORY (INHALATION)
99 L in 100 L
10/29/2009
T.W. Smith Corp.
52563-001
RESPIRATORY (INHALATION)
99.9 L in 1 L
10/15/2018
Apollo Services Inc.
24781-0001
RESPIRATORY (INHALATION)
99 L in 100 L
10/9/2009
MID-SOUTH WELDING SUPPLY, INC.
51400-001
RESPIRATORY (INHALATION)
99 L in 100 L
10/18/2023
Shaw Oxygen Company Inc
54767-001
RESPIRATORY (INHALATION)
995 mL in 1 L
10/18/2023

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

View More Health Canada Approvals

Sign in to access additional Health Canada approved drug information with detailed regulatory data.

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
HELIOX 70/30
Air Liquide Canada Inc.
02416468
Gas - Inhalation
30 %
12/22/2014
OXYGEN USP
airgas canada inc
02214768
Gas - Nasal ,  Oral
100 %
10/17/1996
OXYGEN (FAMILY 1ST MEDICAL)
family 1 st medical ltd
02289962
Gas - Inhalation
99 %
12/19/2006
OXYGEN
matheson gas products canada inc.
00334766
Gas - Inhalation
99.6 %
4/19/1985
OXYGEN (COMPRESSED)
st. thomas elgin general hospital
02238428
Gas - Inhalation
99 %
3/1/1999
LIQUI-MED ANALGESIC GAS
Praxair Canada Inc
00693596
Gas - Inhalation
50 %
12/30/1990
CARBON DIOXIDE USP, OXYGEN USP MEDICAL G.M.
Praxair Canada Inc
02014432
Gas - Inhalation
93 %
12/31/1993
LIQUID OXYGEN
medigas manitoba ltd
02323974
Gas - Inhalation
99 %
8/1/2009
OXYGEN USP
airgas canada inc
02370557
Gas - Inhalation
99 % / V/V
9/7/2011
CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.
Praxair Canada Inc
02014424
Gas - Inhalation
21.5 %
12/31/1993

CIMA AEMPS Drug Approvals

View More CIMA AEMPS Approvals

Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

View More Philippines FDA Approvals

Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

View More Saudi SFDA Approvals

Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

View More Malaysia NPRA Approvals

Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

View More UK EMC Drug Information

Sign in to access additional UK EMC drug information with detailed pharmaceutical data.

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.